83
Participants
Start Date
April 30, 2007
Primary Completion Date
April 30, 2009
Study Completion Date
April 30, 2009
BIIB014
oral administration of BIIB014 at dose to be specified from Part A, given daily for 8 weeks
Placebo
Matched placebo for MTD or MTD-1
Research Sites, Bangalore
Research Site, Chennai
Research Site, Hyderabaad
Research Site, Ludhiana
Research Site, Mumbai
Research Site, New Delhi
Research Site, Secunderabad
Research Site, Ashkelon
Research Site, Jerusalem
Research Site, Ramat Gan
Research Site, Tel Aviv
Research Site, Cambridge
Research Site, Manchester
Research Site, Norwich
Research Site, Salford
Lead Sponsor
Biogen
INDUSTRY